The vitamin D receptor represses transcription of the pituitary transcription factor Pit-1 gene without involvement of the retinoid X receptor

Molecular Endocrinology

Volumn 20, Issue 4, 2006, Pages 735-748

  Seoane, Samuel ^a   Perez Fernandez, Roman ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; HETERODIMER; HISTONE DEACETYLASE 1; LIGAND; MESSENGER RNA; PROTEIN; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR PIT 1; VITAMIN D RECEPTOR;

ARTICLE; BREAST ADENOCARCINOMA; CARCINOMA CELL; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE LOCATION; GENE MAPPING; GENE REPRESSION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR BIOLOGY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

ACETYLATION; ADENOCARCINOMA; BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CALCITRIOL; CELL LINE, TUMOR; DIMERIZATION; DNA; FEMALE; HISTONES; HUMANS; PROMOTER REGIONS (GENETICS); RECEPTORS, CALCITRIOL; RECOMBINANT FUSION PROTEINS; RETINOID X RECEPTORS; TRANSCRIPTION FACTOR PIT-1; TRANSCRIPTION, GENETIC;

MINK CELL FOCUS-FORMING VIRUS;

EID: 33645399517     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2005-0253     Document Type: Article

References (61)

1. Castrillo JL, Theill L, Karin M 1991 Function of the homeodomain protein GHF1 in pituitary cell proliferation. Science 253:197-199
2. Simmons DM, Voss JW, Ingraham HA, Holloway JM, Broide RS, Rosenfeld MG, Swanson LW 1990 Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev 4:695-711
3. Chen R, Ingraham HA, Treacy MN, Albert VR, Wilson L, Rosenfeld MG 1990 Autoregulation of pit-1 gene expression mediated by two cis-active promoter elements. Nature 346:583-586
4. Mangalam HJ, Albert VR, Ingraham HA, Kapiloff MS, Wilson L, Nelson C, Elsholtz H, Rosenfeld MG 1989 A pituitary POU domain protein, Pit-1, activates both growth hormone and prolactin promoters transcriptionally. Genes Dev 3:946-958
5. Dolle P, Castrillo JL, Theill LE, Deerinck T, Ellisman M, Karin M 1990 Expression of GHF-1 protein in mouse pituitaries correlates both temporally and spatially with the onset of growth hormone gene activity. Cell 60:809-820
6. Bamberger AM, Bamberger CM, Pu LP, Puy LA, Loh YP, Asa SL 1995 Expression of Pit-1 messenger ribonucleic acid and protein in the human placenta. J Clin Endocrinol Metab 80:2021-2026
7. Schanke JT, Conwell CM, Durning M, Fisher JM, Golos TG 1997 Pit-1/growth hormone factor 1 splice variant expression in the rhesus monkey pituitary gland and the rhesus and human placenta. J Clin Endocrinol Metab 82:800-807
8. Delhase M, Vergani P, Malur A, Hooghe-Peters EL, Hooghe RJ 1993 The transcription factor Pit-1/GHF-1 is expressed in hemopoietic and lymphoid tissues. Eur J Immunol 23:951-955
9. Gil-Puig C, Blanco M, Garcia-Caballero T, Segura C, Perez-Fernandez R 2002 Pit-1/GHF-1 and GH expression in MCF-7 human breast adenocarcinoma cell line. J Endocrinol 172:161-167
10. Gil-Puig C, Seoane S, Blanco M, Macia M, Garcia-Caballero T, Segura C, Perez-Fernandez R 2005 Pit-1 is expressed in normal and tumorous human breast and regulates GH secretion and cell proliferation. Eur J Endocrinol 153:335-344
11. Asa SL, Puy LA, Lew AM, Sundmark VC, Elsholtz HP 1993 Cell type-specific expression of the pituitary transcription activator Pit-1 in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 77:1275-1280
12. Delhase M, Vergani P, Malur A, Velkeniers B, Tengels E, Trouillas J, Hooghe-Peters EL 1993 Pit-1/GHF-1 expression in pituitary adenomas: further analogy between human adenomas and rat SMtTW tumours. J Mol Endocrinol 11:129-139
13. Sanno N, Teramoto A, Matsuno A, Osamura Y 1996 Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Arch Pathol Lab Med 120:73-77
14. Costoya JA, Garcia-Barros M, Gallego R, Señaris R, Arce VM, Devesa J 1998 Correlation of Pit-1 gene expression and Pit-1 content with proliferation and differentiation in human myeloid leukemic cells. Exp Cell Res 245:132-136
15. Wennbo H, Törnell J 2000 The role of prolactin and growth hormone in breast cancer. Oncogene 19:1071-1076
16. Christakos S, Dhawan P, Liu Y, Peng X, Porta A 2003 New insights into the mechanisms of vitamin D action. J Cell Biochem 88:695-705
17. Jones G, Strugnell SA, DeLuca HF 1998 Current understanding of the molecular actions of vitamin D. Physiol Rev 78:1193-1231
18. Sutton ALM, MacDonald PN 2003 Vitamin D: more than a "Bone-a- fide" hormone. Mol Endocrinol 17:777-791
19. Colston K, Hansen CM 2001 Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer 9:45-59
20. Welsh J, Wietzke JA, Zinser GM, Byrne B, Smith K, Narvaez CJ 2003 Vitamin D-3 receptor as a target for breast cancer prevention. J Nutr 133:2425S-2433S
21. Welsh J, Wietzke JA, Zinser GM, Smyczek S, Romu S, Tribble E, Welsh JC, Byrne B, Narvaez CJ 2003 Impact of the vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer. J Steroid Biochem Mol Biol 83:85-92
22. Jurutka PW, Whitfield GK, Hsieh J-C, Thompson PD, Haussler CA, Haussler MR 2001 Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev Endocr Metab Dis 2:203-216
23. 3 receptor: a network of coactivator interactions. Gene 246:9-21
24. 3 receptors. Cell 65:1255-1266
25. 3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15:5789-5799
26. Candeliere GA, Jurutka PW, Haussler MR, St-Arnaud R 1996 A composite element binding the vitamin D receptor, retinoid X receptor α, and a member of the CTF/NF-1 family of transciption factors mediates the vitamin D responsiveness of the c-fos promoter. Mol Cell Biol 16:584-592
27. 3. Proc Natl Acad Sci USA 89:8097-8101
28. 3-mediated transcriptional repression. Mol Endocrinol 10:672-681
29. 3-mediated transcriptional repression of the granulocyte-macrophage colony-stimulating factor gene: vitamin D receptor competes for DNA binding with NFAT1 and stabilizes c-Jun. Mol Cell Biol 19:4191-4199
30. Tagami T, Lutz WH, Kumar R, Jameson JL 2000 The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Biochem Biophys Res Commun 253:358-363
31. Polly P, Herdick M, Moehren U, Baniahmad A, Heinzel T, Carlberg C 2000 VDR-Alien: a novel, DNA-selective vitamin D3 receptor corepressor partnership. FASEB J 14:1455-1463
32. Yu J, Li Y, Ishizuka T, Guenther MG, Lazar MA 2003 A SANT motif in the SMRT corepressor interprets the histone code and promotes histone deacetylation. EMBO J 22:3403-3410
33. Rhodes SJ, Chen R, DiMattia GE, Scully KM, Kalla K, Lin S-C, Yu V, Rosenfeld MG 1993 A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene. Genes Dev 7:913-932
34. 3 receptor in the absence of the retinoid X receptor. Mol Endocrinol 8:265-273
35. Lefevre C, Imagawa M, Dana S, Grindlay J, Bodner M, Karin M 1987 Tissue specific expression of the human growth hormone gene is conferred in part by the binding of a specific trans-acting factor. EMBO J 6:971-981
36. Nelson C, Albert VR, Elsholtz HP, Lu LI-W, Rosenfeld MG 1988 Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor. Science 239:1400-1405
37. Bodner M, Castrillo JL, Theill LE, Deerinck T, Ellisman M, Karin M 1988 The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell 55:505-518
38. Ingraham HA, Chen R, Mangalam HJ, Elsholtz HP, Flynn SE, Lin CR, Simmons DM, Swanson LW, Rosenfeld MG 1988 A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 55:519-529
39. Palomino T, Sanchez-Pacheco A, Peña P, Aranda A 1998 A direct protein-protein interaction is involved in the cooperation between thyroid hormone and retinoic acid receptors and the transcription factor GHF-1. FASEB J 12:1201-1209
40. Schaufele F, West BL, Baxter JD 1992 Synergistic activation of the rat growth hormone promoter by Pit-1 and the thyroid hormone receptor. Mol Endocrinol 6:656-665
41. Castillo A, Jimenez-Lara A, Tolon R, Aranda A 1999 Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1). Mol Endocrinol 13:1141-1154
42. Sanchez-Pacheco A, Palomino T, Aranda A 1995 Negative regulation of expression of the pituitary-specific transcription factor GHF-1/Pit-1 by thyroid hormones through interference with promoter enhancer elements. Mol Cell Biol 15:6322-6330
43. Macias-Gonzalez M, Carlberg C 2002 Cross-repression, a functional consequence of the physical interaction of non-liganded nuclear receptors and POU domain transcription factors. J Biol Chem 277:18501-18509
44. Quack M, Carlberg C 2000 Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements. J Mol Biol 296:743-756
45. Quack M, Frank C, Carlberg C 2002 Differential nuclear receptor signaling from DR4-type response elements. J Cell Biochem 86:601-612
46. Nishikawa J, Kitaura M, Matsumoto M, Imagawa M, Nishihara T 1994 Difference and similarity of DNA sequence recognized by VDR homodimer and VDR/RXR heterodimer. Nucleic Acids Res 22:2902-2907
47. Glass CK 1994 Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev 15:391-407
48. Kurokawa R, DiRenzo J, Boehm M, Sugarman J, Gloss B, Rosenfeld MG, Heyman RA, Glass CK 1994 Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 371:528-531
49. Kurokawa R, Yu V, Naar CA, Kyakumoto S, Han Z, Silverman S, Rosenfeld MG, Glass CK 1993 Differential orientations of the DNA-binding domain and carboxyterminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev 7:1423-1435
50. Perlmann T, Rangarajan PN, Umesono K, Evans RM 1993 Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev 7:1411-1422
51. Predki PF, Zamble D, Sarkar B, Giguere V 1994 Ordered binding of retinoic acid and retinoid-X receptors to asymmetric response elements involves determinants adjacent to the DNA-binding domain. Mol Endocrinol 8:31-39
52. 3 receptor as a mediator of transrepression of retinoid signaling. J Cell Biol 67:287-296
53. Jepsen K, Rosenfeld MG 2002 Biological roles and mechanistic actions of co-repressor complexes. J Cell Sci 115:689-698
54. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB 2003 Histone deacetylases (HDACs): characterization of classical HDAC family. Biochem J 370:737-749
55. Murayama A, Kim M, Yanagisawa J, Takeyama K-I, Kato S 2004 Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J 23:1598-1608
56. Clevenger CV, Furth PA, Hankinson SE, Schuler LA 2003 The role of prolactin in mammary carcinoma. Endocr Rev 24:1-27
57. Laban C, Bustin SA, Jenkins PJ 2003 The GH-IGF-I axis and breast cancer. Trends Endocrinol Metab 14:28-34
58. Vonderhaar BK 1999 Prolactin involvement in breast cancer. Endocr Relat Cancer 6:389-404
59. Delhase M, Castrillo JL, de la Hoya M, Rajas F, Hooghe-Peters EL 1996 AP-1 and Oct-1 transcription factors down-regulate the expression of the human PIT1/GHF1 gene. J Biol Chem 271:32349-32358
60. Andrews NC, Faller DV 1991 A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499
61. Seoane S, Alonso M, Segura C, Perez-Fernandez R 2002 Localization of a negative vitamin D response sequence in the human growth hormone gene. Biochem Biophys Res Commun 292:250-255